Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Innovent Announces the NMPA Granted New Indication Approval for BYVASDA® (Bevacizumab Biosimilar)

Monday, December 28, 2020

Innovent Biologics Inc a worldclass biopharmaceutical company that develops manufactures and commercializes high quality medicines for the treatment of cancer metabolic autoimmune and other major diseases

A2 Biotherapeutics Enters Into Collaboration Agreement With Merck to Develop Allogeneic Cell Therapy for Solid Tumor Cancers

Thursday, December 24, 2020

A Biotherapeutics wwwabiocom a biotechnology company developing innovative cell therapies for cancer patients with solid tumors today announced that it has entered into an agreement with Merck known as MSD outside the United States and Canada

UCSF and BridgeBio Pharma Collaborate to Accelerate the Development of Therapies for Genetic Diseases

Thursday, December 24, 2020

UC San Francisco UCSF and BridgeBio Pharma Inc announced a partnership to drive the advancement of academic innovations in genetically driven diseases into potential therapeutics for patients

Skyhawk and Vertex Establish a Strategic Collaboration to Discover and Develop Novel Small Molecules that Modulate RNA Splicing for Serious Diseases

Wednesday, December 23, 2020

Skyhawk Therapeutics Inc and Vertex Pharmaceuticals Incorporated announced a strategic research collaboration and licensing agreement aimed at the discovery and development of novel small molecules that modulate RNA splicing for the treatment of seri...

LSBio acquires Absolute Antibody Ltd.

Wednesday, December 23, 2020

LSBio LSBio a leading provider of antibodies and reagents for life science research is pleased to announce the acquisition of Absolute Antibody Ltd based in Redcar United Kingdom and the subsidiary Kerafast The terms of the transaction were not disc...

Allecra Therapeutics and Shanghai Haini Pharmaceutical Announce Exclusive Licensing Agreement for Cefepime/enmetazobactam for Greater China

Tuesday, December 22, 2020

Shanghai Haini Pharmaceutical Co Ltd Shanghai Haini the subsidiary of Yangtze River Pharmaceutical Group YRPG and Allecra Therapeutics Allecra announced that the companies have signed an exclusive licensing agreement under which Shanghai Haini will m...

Pierre Fabre Selects AGC Biologics as CDMO to manufacture the orphan drug ER-004

Tuesday, December 22, 2020

AGC Biologics a leading global Biopharmaceutical Contract Development and Manufacturing Organization CDMO announced its partnership with Laboratoire Pierre Fabre to manufacture ER

Sosei Heptares and GSK Enter Global Collaboration and License Agreement Targeting Immune Disorders of the Digestive System

Monday, December 21, 2020

Sosei Group Corporation announces it has entered into a global collaboration and license agreement with GlaxoSmithKline GSK The singletarget agreement is focused on the discovery and development of selective oral small molecule agonists of GPR

Antengene Announces its U.S. Partner, Karyopharm Therapeutics Inc., has received FDA Approval of XPOVIO® (Selinexor)

Monday, December 21, 2020

Antengene Corporation Limited announced that the US Food and Drug Administration FDA has approved the supplemental New Drug Application sNDA submitted by its partner Karyopharm Therapeutics Inc

Ology Bioservices Enters Phase 1 Clinical Trial for Anti-COVID-19 Monoclonal Antibodies

Saturday, December 19, 2020

Ology Bioservices Inc Ology Bio a biologics contract development and manufacturing organization CDMO announced today that it has begun dosing volunteers in a Phase clinical trial with ADM a cocktail of antiSARSCoV monoclonal antibodies